Literature DB >> 19852885

Omega-3 fatty acids and heart failure.

Roberto Marchioli1, Maria Giuseppina Silletta, Giacomo Levantesi, Raffaella Pioggiarella.   

Abstract

During the past three decades, the protective role of omega (n)-3 polyunsaturated fatty acids (PUFA), mainly eicosapentaenoic acid and docosahexaenoic acid, in patients with coronary heart disease has been widely reported. The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Heart Failure (GISSI-HF) study, a large-scale clinical trial, recently showed that n-3 PUFA (850-882 mg/d) reduced mortality and admission to the hospital for cardiovascular reasons in patients with chronic heart failure (HF) who were already receiving recommended therapies. The favorable effects of n-3 PUFA in GISSI-HF suggest that marine fish oils could confer protection in HF mainly through their antiarrhythmic action and in part by influencing the mechanisms related to HF progression. This article reviews recent clinical and experimental evidence on the effect of n-3 PUFA in coronary heart disease, with particular attention on HF and its pathophysiologic mechanisms.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19852885     DOI： 10.1007/s11883-009-0066-y

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  50 in total

Review 1.  Fish intake, contaminants, and human health: evaluating the risks and the benefits.

Authors:  Dariush Mozaffarian; Eric B Rimm
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

2.  Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

Authors:  Roberto Marchioli; Federica Barzi; Elena Bomba; Carmine Chieffo; Domenico Di Gregorio; Rocco Di Mascio; Maria Grazia Franzosi; Enrico Geraci; Giacomo Levantesi; Aldo Pietro Maggioni; Loredana Mantini; Rosa Maria Marfisi; G Mastrogiuseppe; Nicola Mininni; Gian Luigi Nicolosi; Massimo Santini; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Corrado Tucci; Franco Valagussa
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

3.  Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function.

Authors:  Salvatore Pepe; Peter L McLennan
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

4.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

5.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

6.  (n-3) Long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats.

Authors:  Salvatore Pepe; Peter L McLennan
Journal:  J Nutr       Date:  2007-11       Impact factor: 4.798

7.  Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters.

Authors:  Romina Vargiu; Gian Paolo Littarru; Gavino Faa; Rino Mancinelli
Journal:  Biofactors       Date:  2008       Impact factor: 6.113

8.  Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia.

Authors:  Rainer Schrepf; Tanja Limmert; Peter Claus Weber; Karl Theisen; Alois Sellmayer
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

9.  Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction.

Authors:  Monika K Duda; Karen M O'Shea; Anselm Tintinu; Wenhong Xu; Ramzi J Khairallah; Brian R Barrows; David J Chess; Agnes M Azimzadeh; William S Harris; Victor G Sharov; Hani N Sabbah; William C Stanley
Journal:  Cardiovasc Res       Date:  2008-11-17       Impact factor: 10.787

10.  Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes.

Authors:  Takayuki Matsumoto; Naoaki Nakayama; Keiko Ishida; Tsuneo Kobayashi; Katsuo Kamata
Journal:  J Pharmacol Exp Ther       Date:  2009-01-22       Impact factor: 4.030
View more
  7 in total

1.  Effect of omega-3 on brain natriuretic peptide and echocardiographic findings in heart failure: Double-blind placebo-controlled randomized trial.

Authors:  J Kojuri; M A Ostovan; G R Rezaian; P Archin Dialameh; N Zamiri; M B Sharifkazemi; M Jannati
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

Review 2.  Formation and signaling actions of electrophilic lipids.

Authors:  Francisco J Schopfer; Chiara Cipollina; Bruce A Freeman
Journal:  Chem Rev       Date:  2011-09-20       Impact factor: 60.622

3.  ELOVL2 gene polymorphisms are associated with increases in plasma eicosapentaenoic and docosahexaenoic acid proportions after fish oil supplement.

Authors:  Aseel Alsaleh; Zoitsa Maniou; Fiona J Lewis; Wendy L Hall; Thomas A B Sanders; Sandra D O'Dell
Journal:  Genes Nutr       Date:  2013-11-30       Impact factor: 5.523

4.  Tetradecylthioacetic acid increases fat metabolism and improves cardiac function in experimental heart failure.

Authors:  Erik Øie; Rolf K Berge; Thor Ueland; Christen P Dahl; Thor Edvardsen; Jan Otto Beitnes; Pavol Bohov; Pål Aukrust; Arne Yndestad
Journal:  Lipids       Date:  2012-12-25       Impact factor: 1.880

5.  Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

Authors:  Roberto Marchioli; Giacomo Levantesi
Journal:  Front Physiol       Date:  2012-06-28       Impact factor: 4.566

6.  Association between omega-3 fatty acids consumption and the risk of type 2 diabetes: A meta-analysis of cohort studies.

Authors:  Cai Chen; Yan Yang; Xuefeng Yu; Shuhong Hu; Shiying Shao
Journal:  J Diabetes Investig       Date:  2017-02-03       Impact factor: 4.232

7.  Novel regulatory roles of omega-3 fatty acids in metabolic pathways: a proteomics approach.

Authors:  Abeer A Ahmed; Kayode A Balogun; Natalia V Bykova; Sukhinder K Cheema
Journal:  Nutr Metab (Lond)       Date:  2014-01-17       Impact factor: 4.169
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.